Tiba Biotech

Provider of fully synthetic RNA vaccine drug delivery technology

placeBoston, Massachusetts, United States calendar_todayFounded 2017 groups16 employees language tiba.bio

Innovation

13 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 569 times.

YearFilings
20201
20212
20225
20236
20246
20254
20265

Social engagement

Social engagement: 1.5K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital360%
Private equity120%
Other / undisclosed120%

Recent activity

9 Apr 2026
Partnership
The Pirbright Institute's - Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM)
28 Oct 2025
Partnership
Meat & Livestock Australia and NSW Department of Primary Industries and Regional Development
4 Aug 2025
Milestone
regulatory
Coming soon